Guinandam, Baby Girl .
HRN: 26-06-70 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/24/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
10/24/2024
10/30/2024
IVT
35mg
Q24
Sepsis
Waiting Final Action
Indication: Prophylaxis Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes